Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model

BACKGROUND: Cilostazol(CLZ) has been used as a vasodilating anti-platelet drug clinically and demonstrated to inhibit proliferation of smooth muscle cells and effect on endothelial cells. However, the effect of CLZ on re-endothelialization including bone marrow (BM)-derived endothelial progenitor ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawabe-Yako, Rie, Masaaki, Ii, Masuo, Osamu, Asahara, Takayuki, Itakura, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171459/
https://www.ncbi.nlm.nih.gov/pubmed/21931795
http://dx.doi.org/10.1371/journal.pone.0024646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171459/
https://www.ncbi.nlm.nih.gov/pubmed/21931795
http://dx.doi.org/10.1371/journal.pone.0024646

Ejemplares similares